Mitochondrial permeability transition pore

Last updated

The mitochondrial permeability transition pore (mPTP or MPTP; also referred to as PTP, mTP or MTP) is a protein that is formed in the inner membrane of the mitochondria under certain pathological conditions such as traumatic brain injury and stroke. Opening allows increase in the permeability of the mitochondrial membranes to molecules of less than 1500 daltons in molecular weight. Induction of the permeability transition pore, mitochondrial membrane permeability transition (mPT or MPT), can lead to mitochondrial swelling and cell death through apoptosis or necrosis depending on the particular biological setting. [1]

Contents

Roles in pathology

The MPTP was originally discovered by Haworth and Hunter [2] in 1979 and has been found to be involved in neurodegeneration, hepatotoxicity from Reye-related agents, cardiac necrosis and nervous and muscular dystrophies among other deleterious events inducing cell damage and death. [1] [3] [4] [5]

MPT is one of the major causes of cell death in a variety of conditions. For example, it is key in neuronal cell death in excitotoxicity, in which overactivation of glutamate receptors causes excessive calcium entry into the cell. [6] [7] [8] MPT also appears to play a key role in damage caused by ischemia, as occurs in a heart attack and stroke. [9] However, research has shown that the MPT pore remains closed during ischemia, but opens once the tissues are reperfused with blood after the ischemic period, [10] playing a role in reperfusion injury.

MPT is also thought to underlie the cell death induced by Reye's syndrome, since chemicals that can cause the syndrome, like salicylate and valproate, cause MPT. [11] MPT may also play a role in mitochondrial autophagy. [11] Cells exposed to toxic amounts of Ca2+ ionophores also undergo MPT and death by necrosis. [11]

Structure

While the MPT modulation has been widely studied, little is known about its structure. Initial experiments by Szabó and Zoratti proposed the MPT may comprise Voltage Dependent Anion Channel (VDAC) molecules. Nevertheless, this hypothesis was shown to be incorrect as VDAC−/− mitochondria were still capable to undergo MPT. [12] [13] Further hypothesis by Halestrap's group convincingly suggested the MPT was formed by the inner membrane Adenine Nucleotide Translocase (ANT), but genetic ablation of such protein still led to MPT onset. [14] [15] Thus, the only MPTP components identified so far are the TSPO (previously known as the peripheral benzodiazepine receptor) located in the mitochondrial outer membrane and cyclophilin-D in the mitochondrial matrix. [16] [17] Mice lacking the gene for cyclophilin-D develop normally, but their cells do not undergo Cyclosporin A-sensitive MPT, and they are resistant to necrotic death from ischemia or overload of Ca2+ or free radicals. [18] However, these cells do die in response to stimuli that kill cells through apoptosis, suggesting that MPT does not control cell death by apoptosis. [18]

MPTP blockers

Agents that transiently block MPT include the immune suppressant cyclosporin A (CsA); N-methyl-Val-4-cyclosporin A (MeValCsA), a non-immunosuppressant derivative of CsA; another non-immunosuppressive agent, NIM811, 2-aminoethoxydiphenyl borate (2-APB), [19] bongkrekic acid and alisporivir (also known as Debio-025). TRO40303 is a newly synthetitised MPT blocker developed by Trophos company and currently is in Phase I clinical trial. [20]

Factors in MPT induction

Various factors enhance the likelihood of MPTP opening. In some mitochondria, such as those in the central nervous system, high levels of Ca2+ within mitochondria can cause the MPT pore to open. [21] [22] This is possibly because Ca2+ binds to and activates Ca2+ binding sites on the matrix side of the MPTP. [6] MPT induction is also due to the dissipation of the difference in voltage across the inner mitochondrial membrane (known as transmembrane potential, or Δψ). In neurons and astrocytes, the contribution of membrane potential to MPT induction is complex, see. [23] The presence of free radicals, another result of excessive intracellular calcium concentrations, can also cause the MPT pore to open. [24]

Other factors that increase the likelihood that the MPTP will be induced include the presence of certain fatty acids, [25] and inorganic phosphate. [26] However, these factors cannot open the pore without Ca2+, though at high enough concentrations, Ca2+ alone can induce MPT. [27]

Stress in the endoplasmic reticulum can be a factor in triggering MPT. [28]

Conditions that cause the pore to close or remain closed include acidic conditions, [29] high concentrations of ADP, [24] [30] high concentrations of ATP, [31] and high concentrations of NADH. Divalent cations like Mg2+ also inhibit MPT, because they can compete with Ca2+ for the Ca2+ binding sites on the matrix and/or cytoplasmic side of the MPTP. [23]

Effects

Multiple studies have found the MPT to be a key factor in the damage to neurons caused by excitotoxicity. [6] [7] [8]

The induction of MPT, which increases mitochondrial membrane permeability, causes mitochondria to become further depolarized, meaning that Δψ is abolished. When Δψ is lost, protons and some molecules are able to flow across the outer mitochondrial membrane uninhibited. [7] [8] Loss of Δψ interferes with the production of adenosine triphosphate (ATP), the cell's main source of energy, because mitochondria must have an electrochemical gradient to provide the driving force for ATP production.

In cell damage resulting from conditions such as neurodegenerative diseases and head injury, opening of the mitochondrial permeability transition pore can greatly reduce ATP production, and can cause ATP synthase to begin hydrolysing, rather than producing, ATP. [32] This produces an energy deficit in the cell, just when it most needs ATP to fuel activity of ion pumps.

MPT also allows Ca2+ to leave the mitochondrion, which can place further stress on nearby mitochondria, and which can activate harmful calcium-dependent proteases such as calpain.

Reactive oxygen species (ROS) are also produced as a result of opening the MPT pore. MPT can allow antioxidant molecules such as glutathione to exit mitochondria, reducing the organelles' ability to neutralize ROS. In addition, the electron transport chain (ETC) may produce more free radicals due to loss of components of the ETC, such as cytochrome c, through the MPTP. [33] Loss of ETC components can lead to escape of electrons from the chain, which can then reduce molecules and form free radicals.

MPT causes mitochondria to become permeable to molecules smaller than 1.5 kDa, which, once inside, draw water in by increasing the organelle's osmolar load. [34] This event may lead mitochondria to swell and may cause the outer membrane to rupture, releasing cytochrome c. [34] Cytochrome c can in turn cause the cell to go through apoptosis ("commit suicide") by activating pro-apoptotic factors. Other researchers contend that it is not mitochondrial membrane rupture that leads to cytochrome c release, but rather another mechanism, such as translocation of the molecule through channels in the outer membrane, which does not involve the MPTP. [35]

Much research has found that the fate of the cell after an insult depends on the extent of MPT. If MPT occurs to only a slight extent, the cell may recover, whereas if it occurs more it may undergo apoptosis. If it occurs to an even larger degree the cell is likely to undergo necrotic cell death. [9]

Possible evolutionary purpose

Although the MPTP has been studied mainly in mitochondria from mammalian sources, mitochondria from diverse species also undergo a similar transition. [36] While its occurrence can be easily detected, its purpose still remains elusive. Some have speculated that the regulated opening of the MPT pore may minimize cell injury by causing ROS-producing mitochondria to undergo selective lysosome-dependent mitophagy during nutrient starvation conditions. [37] Under severe stress/pathologic conditions, MPTP opening would trigger injured cell death mainly through necrosis. [38]

There is controversy about the question of whether the MPTP is able to exist in a harmless, "low-conductance" state. This low-conductance state would not induce MPT [6] and would allow certain molecules and ions to cross the mitochondrial membranes. The low-conductance state may allow small ions like Ca2+ to leave mitochondria quickly, in order to aid in the cycling of Ca2+ in healthy cells. [30] [39] If this is the case, MPT may be a harmful side effect of abnormal activity of a usually beneficial MPTP.

MPTP has been detected in mitochondria from plants, [40] yeasts, such as Saccharomyces cerevisiae, [41] birds, such as guinea fowl [42] and primitive vertebrates such as the Baltic lamprey. [43] While the permeability transition is evident in mitochondria from these sources, its sensitivity to its classic modulators may differ when compared with mammalian mitochondria. Nevertheless, CsA-insensitive MPTP can be triggered in mammalian mitochondria given appropriate experimental conditions [44] strongly suggesting this event may be a conserved characteristic throughout the eukaryotic domain. [45]

See also

Related Research Articles

<span class="mw-page-title-main">Mitochondrion</span> Organelle in eukaryotic cells responsible for respiration

A mitochondrion is an organelle found in the cells of most eukaryotes, such as animals, plants and fungi. Mitochondria have a double membrane structure and use aerobic respiration to generate adenosine triphosphate (ATP), which is used throughout the cell as a source of chemical energy. They were discovered by Albert von Kölliker in 1857 in the voluntary muscles of insects. The term mitochondrion was coined by Carl Benda in 1898. The mitochondrion is popularly nicknamed the "powerhouse of the cell", a phrase coined by Philip Siekevitz in a 1957 article of the same name.

<span class="mw-page-title-main">Cytochrome c</span> Protein-coding gene in the species Homo sapiens

The cytochrome complex, or cyt c, is a small hemeprotein found loosely associated with the inner membrane of the mitochondrion where it plays a critical role in cellular respiration. It transfers electrons between Complexes III and IV. Cytochrome c is highly water-soluble, unlike other cytochromes. It is capable of undergoing oxidation and reduction as its iron atom converts between the ferrous and ferric forms, but does not bind oxygen. It also plays a major role in cell apoptosis. In humans, cytochrome c is encoded by the CYCS gene.

<span class="mw-page-title-main">Ciclosporin</span> Chemical compound

Ciclosporin, also spelled cyclosporine and cyclosporin, is a calcineurin inhibitor, used as an immunosuppressant medication. It is taken orally or intravenously for rheumatoid arthritis, psoriasis, Crohn's disease, nephrotic syndrome, eczema, and in organ transplants to prevent rejection. It is also used as eye drops for keratoconjunctivitis sicca.

<span class="mw-page-title-main">Reperfusion injury</span> Tissue damage after return of blood supply following ischemia or hypoxia

Reperfusion injury, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue after a period of ischemia or lack of oxygen. The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than restoration of normal function.

Cardiolipin is an important component of the inner mitochondrial membrane, where it constitutes about 20% of the total lipid composition. It can also be found in the membranes of most bacteria. The name "cardiolipin" is derived from the fact that it was first found in animal hearts. It was first isolated from the beef heart in the early 1940s by Mary C. Pangborn. In mammalian cells, but also in plant cells, cardiolipin (CL) is found almost exclusively in the inner mitochondrial membrane, where it is essential for the optimal function of numerous enzymes that are involved in mitochondrial energy metabolism.

<span class="mw-page-title-main">Cyclophilin</span>

Cyclophilins (CYPs) are a family of proteins named after their ability to bind to ciclosporin, an immunosuppressant which is usually used to suppress rejection after internal organ transplants. They are found in all domains of life. These proteins have peptidyl prolyl isomerase activity, which catalyzes the isomerization of peptide bonds from trans form to cis form at proline residues and facilitates protein folding.

<span class="mw-page-title-main">Mitochondrial membrane transport protein</span>

Mitochondrial membrane transport proteins, also known as mitochondrial carrier proteins, are proteins which exist in the membranes of mitochondria. They serve to transport molecules and other factors, such as ions, into or out of the organelles. Mitochondria contain both an inner and outer membrane, separated by the inter-membrane space, or inner boundary membrane. The outer membrane is porous, whereas the inner membrane restricts the movement of all molecules. The two membranes also vary in membrane potential and pH. These factors play a role in the function of mitochondrial membrane transport proteins. There are 53 discovered human mitochondrial membrane transporters, with many others that are known to still need discovered.

<span class="mw-page-title-main">Adenine nucleotide translocator</span> Class of transport proteins

Adenine nucleotide translocator (ANT), also known as the ADP/ATP translocase (ANT), ADP/ATP carrier protein (AAC) or mitochondrial ADP/ATP carrier, exchanges free ATP with free ADP across the inner mitochondrial membrane. ANT is the most abundant protein in the inner mitochondrial membrane and belongs to mitochondrial carrier family.

<span class="mw-page-title-main">Voltage-dependent anion channel</span> Class of porin ion channels in the outer mitochondrial membrane

Voltage-dependent anion channels, or mitochondrial porins, are a class of porin ion channel located on the outer mitochondrial membrane. There is debate as to whether or not this channel is expressed in the cell surface membrane.

<span class="mw-page-title-main">PRKCE</span> Protein-coding gene in the species Homo sapiens

Protein kinase C epsilon type (PKCε) is an enzyme that in humans is encoded by the PRKCE gene. PKCε is an isoform of the large PKC family of protein kinases that play many roles in different tissues. In cardiac muscle cells, PKCε regulates muscle contraction through its actions at sarcomeric proteins, and PKCε modulates cardiac cell metabolism through its actions at mitochondria. PKCε is clinically significant in that it is a central player in cardioprotection against ischemic injury and in the development of cardiac hypertrophy.

<span class="mw-page-title-main">Peptidylprolyl isomerase D</span> Protein-coding gene in the species Homo sapiens

Peptidylprolyl isomerase D (cyclophilin D), also known as PPID, is an enzyme which in humans is encoded by the PPID gene on chromosome 4. As a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family, this protein catalyzes the cis-trans isomerization of proline imidic peptide bonds, which allows it to facilitate folding or repair of proteins. In addition, PPID participates in many biological processes, including mitochondrial metabolism, apoptosis, redox, and inflammation, as well as in related diseases and conditions, such as ischemic reperfusion injury, AIDS, and cancer.

<span class="mw-page-title-main">VDAC1</span> Protein-coding gene in the species Homo sapiens

Voltage-dependent anion-selective channel 1 (VDAC-1) is a beta barrel protein that in humans is encoded by the VDAC1 gene located on chromosome 5. It forms an ion channel in the outer mitochondrial membrane (OMM) and also the outer cell membrane. In the OMM, it allows ATP to diffuse out of the mitochondria into the cytoplasm. In the cell membrane, it is involved in volume regulation. Within all eukaryotic cells, mitochondria are responsible for synthesis of ATP among other metabolite needed for cell survival. VDAC1 therefore allows for communication between the mitochondrion and the cell mediating the balance between cell metabolism and cell death. Besides metabolic permeation, VDAC1 also acts as a scaffold for proteins such as hexokinase that can in turn regulate metabolism.

<span class="mw-page-title-main">PPIF</span> Protein-coding gene in the species Homo sapiens

Peptidyl-prolyl cis-trans isomerase, mitochondrial (PPIF) is an enzyme that in humans is encoded by the PPIF gene. It has also been referred to as, but should not be confused with, cyclophilin D (CypD), which is encoded by the PPID gene. As a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family, this protein catalyzes the cis-trans isomerization of proline imidic peptide bonds, which allows it to facilitate folding or repair of proteins. PPIF is a major component of the mitochondrial permeability transition pore (MPTP) and, thus, highly involved in mitochondrial metabolism and apoptosis, as well as in mitochondrial diseases and related conditions, including cardiac diseases, neurodegenerative diseases, and muscular dystrophy. In addition, PPIF participates in inflammation, as well as in ischemic reperfusion injury, AIDS, and cancer.

<span class="mw-page-title-main">VDAC2</span> Protein-coding gene in the species Homo sapiens

Voltage-dependent anion-selective channel protein 2 is a protein that in humans is encoded by the VDAC2 gene on chromosome 10. This protein is a voltage-dependent anion channel and shares high structural homology with the other VDAC isoforms. VDACs are generally involved in the regulation of cell metabolism, mitochondrial apoptosis, and spermatogenesis. Additionally, VDAC2 participates in cardiac contractions and pulmonary circulation, which implicate it in cardiopulmonary diseases. VDAC2 also mediates immune response to infectious bursal disease (IBD).

<span class="mw-page-title-main">Norbormide</span> Chemical compound

Norbormide is a toxic compound used as a rodenticide. It has several mechanisms of action, acting as a vasoconstrictor and calcium channel blocker, but is selectively toxic to rats and has relatively low toxicity to other species, due to a species specific action of opening the permeability transition pores in rat mitochondria.

<span class="mw-page-title-main">Bcl-2 family</span>

The Bcl-2 family consists of a number of evolutionarily-conserved proteins that share Bcl-2 homology (BH) domains. The Bcl-2 family is most notable for their regulation of apoptosis, a form of programmed cell death, at the mitochondrion. The Bcl-2 family proteins consists of members that either promote or inhibit apoptosis, and control apoptosis by governing mitochondrial outer membrane permeabilization (MOMP), which is a key step in the intrinsic pathway of apoptosis. A total of 25 genes in the Bcl-2 family were identified by 2008.

<span class="mw-page-title-main">Rottlerin</span> Chemical compound

Rottlerin (mallotoxin) is a polyphenol natural product isolated from the Asian tree Mallotus philippensis. Rottlerin displays a complex spectrum of pharmacology.

Immunogenic cell death is any type of cell death eliciting an immune response. Both accidental cell death and regulated cell death can result in immune response. Immunogenic cell death contrasts to forms of cell death that do not elicit any response or even mediate immune tolerance.

The ion channel hypothesis of Alzheimer's disease (AD), also known as the channel hypothesis or the amyloid beta ion channel hypothesis, is a more recent variant of the amyloid hypothesis of AD, which identifies amyloid beta (Aβ) as the underlying cause of neurotoxicity seen in AD. While the traditional formulation of the amyloid hypothesis pinpoints insoluble, fibrillar aggregates of Aβ as the basis of disruption of calcium ion homeostasis and subsequent apoptosis in AD, the ion channel hypothesis in 1993 introduced the possibility of an ion-channel-forming oligomer of soluble, non-fibrillar Aβ as the cytotoxic species allowing unregulated calcium influx into neurons in AD.

<span class="mw-page-title-main">Mitochondria associated membranes</span> Cellular structure

Mitochondria-associated membranes (MAMs) represent regions of the endoplasmic reticulum (ER) which are reversibly tethered to mitochondria. These membranes are involved in import of certain lipids from the ER to mitochondria and in regulation of calcium homeostasis, mitochondrial function, autophagy and apoptosis. They also play a role in development of neurodegenerative diseases and glucose homeostasis.

References

  1. 1 2 Lemasters, J. J.; Theruvath, T. P.; Zhong, Z.; Nieminen, A. L. (2009). "Mitochondrial calcium and the permeability transition in cell death". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1787 (11): 1395–1401. doi:10.1016/j.bbabio.2009.06.009. PMC   2730424 . PMID   19576166.
  2. Haworth, R. A.; Hunter, D. R. (1979). "The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site". Archives of Biochemistry and Biophysics. 195 (2): 460–467. doi:10.1016/0003-9861(79)90372-2. PMID   38751.
  3. Fiskum, G. (2000). "Mitochondrial participation in ischemic and traumatic neural cell death". Journal of Neurotrauma. 17 (10): 843–855. doi:10.1089/neu.2000.17.843. PMID   11063052.
  4. Bernardi, P.; Bonaldo, P. (2008). "Dysfunction of Mitochondria and Sarcoplasmic Reticulum in the Pathogenesis of Collagen VI Muscular Dystrophies". Annals of the New York Academy of Sciences. 1147 (1): 303–311. Bibcode:2008NYASA1147..303B. doi:10.1196/annals.1427.009. PMID   19076452. S2CID   45028337.
  5. Baines, C. P. (2010). "The Cardiac Mitochondrion: Nexus of Stress". Annual Review of Physiology. 72: 61–80. doi:10.1146/annurev-physiol-021909-135929. PMID   20148667.
  6. 1 2 3 4 Ichas, F.; Mazat, J. P. (1998). "From calcium signaling to cell death: Two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1366 (1–2): 33–50. doi: 10.1016/S0005-2728(98)00119-4 . PMID   9714722.
  7. 1 2 3 Schinder, A. F.; Olson, E. C.; Spitzer, N. C.; Montal, M. (1996). "Mitochondrial dysfunction is a primary event in glutamate neurotoxicity". The Journal of Neuroscience. 16 (19): 6125–6133. doi:10.1523/JNEUROSCI.16-19-06125.1996. PMC   6579180 . PMID   8815895.
  8. 1 2 3 White, R. J.; Reynolds, I. J. (1996). "Mitochondrial depolarization in glutamate-stimulated neurons: An early signal specific to excitotoxin exposure". The Journal of Neuroscience. 16 (18): 5688–5697. doi:10.1523/JNEUROSCI.16-18-05688.1996. PMC   6578963 . PMID   8795624.
  9. 1 2 Honda, H. M.; Ping, P. (2006). "Mitochondrial Permeability Transition in Cardiac Cell Injury and Death". Cardiovascular Drugs and Therapy. 20 (6): 425–432. doi:10.1007/s10557-006-0642-0. PMID   17171295. S2CID   12969118.
  10. Bopassa, J. C.; Michel, P.; Gateau-Roesch, O.; Ovize, M.; Ferrera, R. (2005). "Low-pressure reperfusion alters mitochondrial permeability transition". AJP: Heart and Circulatory Physiology. 288 (6): H2750–H2755. doi:10.1152/ajpheart.01081.2004. PMID   15653760. S2CID   12960249.
  11. 1 2 3 Lemasters, J. J.; Nieminen, A. L.; Qian, T.; Trost, L. C.; Elmore, S. P.; Nishimura, Y.; Crowe, R. A.; Cascio, W. E.; Bradham, C. A.; Brenner, D. A.; Herman, B. (1998). "The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1366 (1–2): 177–196. doi: 10.1016/S0005-2728(98)00112-1 . PMID   9714796.
  12. Szabó, I.; Zoratti, M. (1993). "The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore". FEBS Letters. 330 (2): 201–205. doi: 10.1016/0014-5793(93)80273-w . PMID   7689983.
  13. Baines, C. P.; Kaiser, R. A.; Sheiko, T.; Craigen, W. J.; Molkentin, J. D. (2007). "Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death". Nature Cell Biology. 9 (5): 550–555. doi:10.1038/ncb1575. PMC   2680246 . PMID   17417626.
  14. Kokoszka, J. E.; Waymire, K. G.; Levy, S. E.; Sligh, J. E.; Cai, J.; Jones, D. P.; MacGregor, G. R.; Wallace, D. C. (2004). "The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore". Nature. 427 (6973): 461–465. Bibcode:2004Natur.427..461K. doi:10.1038/nature02229. PMC   3049806 . PMID   14749836.
  15. Varanyuwatana, P.; Halestrap, A. P. (2012). "The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore". Mitochondrion. 12 (1): 120–125. doi:10.1016/j.mito.2011.04.006. PMC   3281194 . PMID   21586347.
  16. Sileikyte, J.; Petronilli, V.; Zulian, A.; Dabbeni-Sala, F.; Tognon, G.; Nikolov, P.; Bernardi, P.; Ricchelli, F. (2010). "Regulation of the Inner Membrane Mitochondrial Permeability Transition by the Outer Membrane Translocator Protein (Peripheral Benzodiazepine Receptor)". Journal of Biological Chemistry. 286 (2): 1046–1053. doi: 10.1074/jbc.M110.172486 . PMC   3020711 . PMID   21062740.
  17. Baines, C. P.; Kaiser, R. A.; Purcell, N. H.; Blair, N. S.; Osinska, H.; Hambleton, M. A.; Brunskill, E. W.; Sayen, M. R.; Gottlieb, R. A.; Dorn, G. W.; Robbins, J.; Molkentin, J. D. (2005). "Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death". Nature. 434 (7033): 658–662. Bibcode:2005Natur.434..658B. doi:10.1038/nature03434. PMID   15800627. S2CID   4418460.
  18. 1 2 Nakagawa, T.; Shimizu, S.; Watanabe, T.; Yamaguchi, O.; Otsu, K.; Yamagata, H.; Inohara, H.; Kubo, T.; Tsujimoto, Y. (2005). "Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death". Nature. 434 (7033): 652–658. Bibcode:2005Natur.434..652N. doi:10.1038/nature03317. PMID   15800626. S2CID   4365004.
  19. Chinopoulos, C.; Starkov, A. A.; Fiskum, G. (2003). "Cyclosporin A-insensitive Permeability Transition in Brain Mitochondria: INHIBITION BY 2-AMINOETHOXYDIPHENYL BORATE". Journal of Biological Chemistry. 278 (30): 27382–27389. doi: 10.1074/jbc.M303808200 . PMID   12750371.
  20. Le Lamer S (Feb 2014). "Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial". J Transl Med. 12: 38. doi: 10.1186/1479-5876-12-38 . PMC   3923730 . PMID   24507657.
  21. Brustovetsky, N.; Brustovetsky, T.; Jemmerson, R.; Dubinsky, J. M. (2002). "Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane". Journal of Neurochemistry. 80 (2): 207–218. doi: 10.1046/j.0022-3042.2001.00671.x . PMID   11902111.
  22. Hunter, D. R.; Haworth, R. A. (1979). "The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms". Archives of Biochemistry and Biophysics. 195 (2): 453–459. doi:10.1016/0003-9861(79)90371-0. PMID   383019.
  23. 1 2 Doczi, J.; Turiák, L.; Vajda, S.; Mándi, M.; Töröcsik, B.; Gerencser, A. A.; Kiss, G.; Konràd, C.; Adam-Vizi, V.; Chinopoulos, C. (2010). "Complex Contribution of Cyclophilin D to Ca2+-induced Permeability Transition in Brain Mitochondria, with Relation to the Bioenergetic State". Journal of Biological Chemistry. 286 (8): 6345–6353. doi: 10.1074/jbc.M110.196600 . PMC   3057831 . PMID   21173147.
  24. 1 2 Brustovetsky, N.; Brustovetsky, T.; Purl, K. J.; Capano, M.; Crompton, M.; Dubinsky, J. M. (2003). "Increased susceptibility of striatal mitochondria to calcium-induced permeability transition". The Journal of Neuroscience. 23 (12): 4858–4867. doi:10.1523/JNEUROSCI.23-12-04858.2003. PMC   6741171 . PMID   12832508.
  25. García-Ruiz, C.; Colell, A.; París, R.; Fernández-Checa, J. C. (2000). "Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation". FASEB Journal. 14 (7): 847–858. doi: 10.1096/fasebj.14.7.847 . PMID   10783138. S2CID   2089247.
  26. Nicholls, D. G.; Brand, M. D. (1980). "The nature of the calcium ion efflux induced in rat liver mitochondria by the oxidation of endogenous nicotinamide nucleotides". The Biochemical Journal. 188 (1): 113–118. doi:10.1042/bj1880113. PMC   1162544 . PMID   7406874.
  27. Gunter, T. E.; Gunter, K. K.; Sheu, S. S.; Gavin, C. E. (1994). "Mitochondrial calcium transport: Physiological and pathological relevance". The American Journal of Physiology. 267 (2 Pt 1): C313–C339. doi:10.1152/ajpcell.1994.267.2.C313. PMID   8074170.
  28. Deniaud, A.; Sharaf El Dein, O.; Maillier, E.; Poncet, D.; Kroemer, G.; Lemaire, C.; Brenner, C. (2007). "Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis". Oncogene. 27 (3): 285–299. doi: 10.1038/sj.onc.1210638 . PMID   17700538.
  29. Friberg, H.; Wieloch, T. (2002). "Mitochondrial permeability transition in acute neurodegeneration". Biochimie. 84 (2–3): 241–250. doi:10.1016/s0300-9084(02)01381-0. PMID   12022955.
  30. 1 2 Hunter, D. R.; Haworth, R. A. (1979). "The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release". Archives of Biochemistry and Biophysics. 195 (2): 468–477. doi:10.1016/0003-9861(79)90373-4. PMID   112926.
  31. Beutner, G.; Rück, A.; Riede, B.; Brdiczka, D. (1998). "Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases". Biochimica et Biophysica Acta (BBA) - Biomembranes. 1368 (1): 7–18. doi: 10.1016/s0005-2736(97)00175-2 . PMID   9459579.
  32. Stavrovskaya, I. G.; Kristal, B. S. (2005). "The powerhouse takes control of the cell: Is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?". Free Radical Biology and Medicine. 38 (6): 687–697. doi:10.1016/j.freeradbiomed.2004.11.032. PMID   15721979.
  33. Luetjens, C. M.; Bui, N. T.; Sengpiel, B.; Münstermann, G.; Poppe, M.; Krohn, A. J.; Bauerbach, E.; Krieglstein, J.; Prehn, J. H. (2000). "Delayed mitochondrial dysfunction in excitotoxic neuron death: Cytochrome c release and a secondary increase in superoxide production". The Journal of Neuroscience. 20 (15): 5715–5723. doi:10.1523/JNEUROSCI.20-15-05715.2000. PMC   6772544 . PMID   10908611.
  34. 1 2 Büki, A.; Okonkwo, D. O.; Wang, K. K.; Povlishock, J. T. (2000). "Cytochrome c release and caspase activation in traumatic axonal injury". The Journal of Neuroscience. 20 (8): 2825–2834. doi:10.1523/JNEUROSCI.20-08-02825.2000. PMC   6772193 . PMID   10751434.
  35. Priault, M.; Chaudhuri, B.; Clow, A.; Camougrand, N.; Manon, S. (1999). "Investigation of bax-induced release of cytochrome c from yeast mitochondria permeability of mitochondrial membranes, role of VDAC and ATP requirement". European Journal of Biochemistry. 260 (3): 684–691. doi: 10.1046/j.1432-1327.1999.00198.x . PMID   10102996.
  36. Azzolin, L.; Von Stockum, S.; Basso, E.; Petronilli, V.; Forte, M. A.; Bernardi, P. (2010). "The mitochondrial permeability transition from yeast to mammals". FEBS Letters. 584 (12): 2504–2509. doi:10.1016/j.febslet.2010.04.023. PMC   2878904 . PMID   20398660.
  37. Kim, I.; Rodriguez-Enriquez, S.; Lemasters, J. J. (2007). "Selective degradation of mitochondria by mitophagy". Archives of Biochemistry and Biophysics. 462 (2): 245–253. doi:10.1016/j.abb.2007.03.034. PMC   2756107 . PMID   17475204.
  38. Haworth RA and Hunter DR. 2001. Ca2+-induced transition in mitochondria: A cellular catastrophe? Chapter 6 In Mitochondria in pathogenesis. Lemasters JJ and Nieminen AL, eds. Kluwer Academic/Plenum Publishers. New York. Pages 115 - 124.
  39. Altschuld, R. A.; Hohl, C. M.; Castillo, L. C.; Garleb, A. A.; Starling, R. C.; Brierley, G. P. (1992). "Cyclosporin inhibits mitochondrial calcium efflux in isolated adult rat ventricular cardiomyocytes". The American Journal of Physiology. 262 (6 Pt 2): H1699–H1704. doi:10.1152/ajpheart.1992.262.6.H1699. PMID   1377876.
  40. Curtis, M. J.; Wolpert, T. J. (2002). "The oat mitochondrial permeability transition and its implication in victorin binding and induced cell death". The Plant Journal. 29 (3): 295–312. doi: 10.1046/j.0960-7412.2001.01213.x . PMID   11844107.
  41. Jung, D. W.; Bradshaw, P. C.; Pfeiffer, D. R. (1997). "Properties of a Cyclosporin-insensitive Permeability Transition Pore in Yeast Mitochondria". Journal of Biological Chemistry. 272 (34): 21104–21112. doi: 10.1074/jbc.272.34.21104 . PMID   9261114.
  42. Vedernikov, A. A.; Dubinin, M. V.; Zabiakin, V. A.; Samartsev, V. N. (2015). "Ca2+-dependent nonspecific permeability of the inner membrane of liver mitochondria in the guinea fowl (Numida meleagris)". Journal of Bioenergetics and Biomembranes. 47 (3): 235–242. doi:10.1007/s10863-015-9606-z. PMID   25690874. S2CID   5537939.
  43. Savina, M. V.; Emelyanova, L. V.; Belyaeva, E. A. (2006). "Bioenergetic parameters of lamprey and frog liver mitochondria during metabolic depression and activity". Comparative Biochemistry and Physiology B. 145 (3–4): 296–305. doi:10.1016/j.cbpb.2006.07.011. PMID   17070716.
  44. García, N.; Martínez-Abundis, E.; Pavón, N.; Chávez, E. (2007). "On the Opening of an Insensitive Cyclosporin a Non-specific Pore by Phenylarsine Plus Mersalyl". Cell Biochemistry and Biophysics . 49 (2): 84–90. doi:10.1007/s12013-007-0047-0. PMID   17906363. S2CID   23183822.
  45. Uribe-Carvajal, S.; Luévano-Martínez, L. S. A.; Guerrero-Castillo, S.; Cabrera-Orefice, A.; Corona-De-La-Peña, N. A.; Gutiérrez-Aguilar, M. (2011). "Mitochondrial Unselective Channels throughout the eukaryotic domain". Mitochondrion. 11 (3): 382–390. doi:10.1016/j.mito.2011.02.004. PMID   21385626.